AstraZeneca pursues oral PCSK9 pill to compete with Merck's Lipfendra
AstraZeneca developing competing daily PCSK9 pill to rival Merck's Lipfendra.
02 / Read
Start with the essentials. Stay for the perspective.
AstraZeneca developing competing daily PCSK9 pill to rival Merck's Lipfendra.
FDA approves Merck's Lipfendra oral cholesterol pill, reducing LDL by 55-60% at $10.50 daily.
MLB schedules 2027 season from March 24 to September 26 as labor contract expires December 1, 2026.
Mortgage rates rise to 6.55% (30-year) and 5.93% (15-year) as housing reform measures take effect.
White House task force examines China's election interference capabilities as part of expanded election security focus.
Courts restrict federal election initiatives while Congress debates security funding amid federal-state authority disputes.
Trump's $1.2 billion crypto profits complicate his prediction market stance.
Trump administration fires election officials and pushes stricter voting requirements through courts and Congress.
Trump schedules primetime address on elections; Democrats fear misinformation, Republicans uncertain of content.
White House and Kalshi implement new policies to prevent insider trading on prediction markets.
White House teleprompter operator investigated for insider trading using advance speech knowledge on prediction markets.
Trump Media hired firms to illegally scrape Truth Social user data, contradicting official platform policies.